Antithrombotic Therapy in Peripheral Arterial Occlusive Disease
- 1 September 2004
- Vol. 126 (3) , 609S-626S
- https://doi.org/10.1378/chest.126.3_suppl.609s
Abstract
No abstract availableKeywords
This publication has 131 references indexed in Scilit:
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- Protamine use during peripheral vascular surgery: A prospective randomized trialJournal of Vascular Surgery, 1995
- Relationship of severity of lower limb peripheral vascular disease to mortality and morbidity: A six-year follow-up studyJournal of Vascular Surgery, 1989
- Association of Protamine IgE and IgG Antibodies with Life-Threatening Reactions to Intravenous ProtamineNew England Journal of Medicine, 1989
- Ticlopidine in the Treatment of Peripheral Occlusive Arterial DiseaseSeminars in Thrombosis and Hemostasis, 1989
- Improved graft patency in patients treated with platelet-inhibiting therapy after coronary bypass surgery.Circulation, 1985
- The prevalence of peripheral arterial disease in a defined population.Circulation, 1985
- In vivo quantitation of platelet deposition on human peripheral arterial bypass grafts using indium-111-labeled plateletsThe American Journal of Cardiology, 1983
- Pentoxifylline efficacy in the treatment of intermittent claudication: Multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patientsAmerican Heart Journal, 1982
- Naftidrofuryl for ischaemic rest pain: A controlled trialBritish Journal of Surgery, 1981